The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma

Clinical and Experimental Dermatology

Volumn 36, Issue 7, 2011, Pages 788-792

  Fujii, M ^a   Honma, M ^a   Takahashi, H ^a   Ishida Yamamoto, A ^a   Iizuka, H ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; TISSUE SECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CORTACTIN; DIAGNOSIS, DIFFERENTIAL; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; KI-67 ANTIGEN; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052964850     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04118.x     Document Type: Article

References (21)

1. Goldenhersh MA, Olsen TG,. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma. J Am Acad Dermatol 1984; 10: 372-8. (Pubitemid 14181968)
2. Hodak E, Jones RE, Ackerman AB,. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332-42.
3. LeBoit PE,. Can we understand keratoacanthoma? Am J Dermatopathol 2002; 24: 166-8.
4. Karaa A, Khachemoune A,. Keratoacanthoma. A tumor in search of a classification. Int J Dermatol 2007; 46: 671-8.
5. Oakley F, Mann J, Nailard S, et al. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol 2005; 166: 695-708. (Pubitemid 40315627)
6. Curran JE, Weinstein SR, Griffiths LR,. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002; 188: 103-7. (Pubitemid 35292335)
7. Sur I, Ulvmar M, Toftgčrd R,. The two-faced NF-kappaB in the skin. Int Rev Immunol 2008; 27: 205-27.
8. Perez-Moreno M, Davis MA, Wong E, et al. p120-catenin mediates inflammatory responses in the skin. Cell 2006; 124: 631-44. (Pubitemid 43199446)
9. Ren G, Crampton MS, Yap AS,. Cortactin: coordinating adhesion and the actin cytoskeleton at cellular protrusions. Cell Motil Cytoskeleton 2009; 66: 865-73.
10. Wu H, Parsons JT,. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120: 1417-26. (Pubitemid 23081688)
11. Slater M, Barden JA,. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology 2005; 47: 170-8. (Pubitemid 41113120)
12. Honma M, Kato N, Hashimoto M, et al. Subungual keratoacanthoma. analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma. Clin Exp Dermatol 2011; 36: 57-62.
13. Takata M, Suzuki T, Ansai S, et al. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): its usefulness as an adjunctive diagnostic tool for melanocytic tumors. J Dermatol Sci 2005; 40: 51-7. (Pubitemid 41383898)
14. Costa MJ, Walls J, Ames P, Roth LM,. Transformation in recurrent ovarian granulosa cell tumors. Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996; 27: 274-81. (Pubitemid 26078908)
15. Patel A, Halliday G, Cooke B, Barnetson R,. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131: 789-98. (Pubitemid 24373956)
16. Tanja B, Gordana Z, Miran C, Ita H,. Possible key role of granzyme B in keratoacanthoma regression. Med Hypotheses 2006; 66: 1129-32.
17. Connolly M, Narayan S, Oxley J, de Berker DA,. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma. Clin Exp Dermatol 2008; 33: 625-8.
18. Ribeiro D, Narikawa S, Marques ME,. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Pathol Res Pract 2008; 204: 97-104.
19. Tsuji T,. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le (Y) expression. J Cutan Pathol 1997; 24: 409-15. (Pubitemid 27374502)
20. Cramer SF,. Subungual keratoacanthoma. A benign bone-eroding neoplasm of the distal phalanx. Am J Clin Pathol 1981; 75: 425-9. (Pubitemid 11114082)
21. Kobielak A, Fuchs E,. Links between α-catenin, NF-κB, and squamous cell carcinoma in skin. Proc Natl Acad Sci USA 2006; 103: 2322-7. (Pubitemid 43271668)